BSG and acute myeloid leukemia: Recently, we also demonstrated that CD147, whose overexpression promotes leukemic cells proliferation, is a potential therapeutic target in AML patients and its inhibitor AC-73 is an anti-proliferative drug that induces autophagy in leukemic cells (22, 26).